Cristina Jauset joined Flagship Pioneering in 2023 as an Associate following the completion of the Flagship Pioneering Fellowship in 2022. As a member of Flagship General Partner Ignacio Martinez’s origination team, Cristina is focused on company creation. She collaborates with a team of entrepreneurial scientists, engaging in the exploration of emerging biological domains and contributing to the development of the scientific vision, business strategy, and intellectual property for the Flagship's groundbreaking startup ventures.
During her doctoral studies at the University of Cambridge, she conducted cancer research in Professor Greg Hannon’s laboratory. Her research focused on the investigation of clonal heterogeneity and the interactions between immune cells and cancer cells. She combined mouse models, single-cell sequencing, spatial transcriptomics and proteomics and gene editing to unravel the molecular mechanisms underlying lymphatic metastasis in breast cancer. While a Ph.D. student, she established and led a collaboration that resulted in work featured in the scientific journal Nature. She was also part of the CRUK Grand Challenge funded IMAXT team. In this role, she collaborated with an interdisciplinary group of scientists across eight institutions to generate molecularly annotated three-dimensional maps of tumors for their visualization in virtual reality. Prior to her graduate studies, Cristina conducted numerous research projects in areas such as cardiac regeneration, alternative splicing, and genome instability.
Cristina has also participated in several entrepreneurial initiatives. She was awarded first prize at the international competition “Merck KGaA Innovation Cup 2020”, where together with fellow entrepreneurial scientists, she proposed an innovative platform for the discovery and development of a new-in-class protein degrader. She completed the EnterpriseTECH PhD+ program at the Judge Business School at the University of Cambridge. She also served as a venture promoter at the healthcare accelerator, Start Codon, where she conducted due diligence for early-stage companies.
Cristina received her Ph.D. and an M.Phil. from the University of Cambridge. She graduated summa cum laude with a B.S. in Biomedical Sciences from University of Lleida, earning her second-place recognition at the Spanish National Award for Excellence in Academic Performance in Life Sciences.